These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24008363)

  • 1. Anticancer effects of the engineered stem cells transduced with therapeutic genes via a selective tumor tropism caused by vascular endothelial growth factor toward HeLa cervical cancer cells.
    Kim HS; Yi BR; Hwang KA; Kim SU; Choi KC
    Mol Cells; 2013 Oct; 36(4):347-54. PubMed ID: 24008363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use.
    Kim KY; Yi BR; Lee HR; Kang NH; Jeung EB; Kim SU; Choi KC
    Int J Oncol; 2012 Apr; 40(4):1097-104. PubMed ID: 22159640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
    Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
    Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.
    Yi BR; Park MA; Lee HR; Kang NH; Choi KJ; Kim SU; Choi KC
    Mol Oncol; 2013 Jun; 7(3):543-54. PubMed ID: 23403306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically engineered stem cells expressing cytosine deaminase and interferon-β migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects.
    Yi BR; O SN; Kang NH; Hwang KA; Kim SU; Jeung EB; Kim YB; Heo GJ; Choi KC
    Int J Oncol; 2011 Oct; 39(4):833-9. PubMed ID: 21769425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
    Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
    Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells.
    Yi BR; Hwang KA; Kim YB; Kim SU; Choi KC
    Int J Mol Sci; 2012 Sep; 13(10):12519-32. PubMed ID: 23202910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferon-beta via apoptotic pathway in the metastatic mouse model of breast cancer.
    Yi BR; Kim SU; Choi KC
    Oncotarget; 2016 Feb; 7(5):5985-99. PubMed ID: 26716512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
    Park GT; Kim SU; Choi KC
    Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth.
    Kim KY; Kim SU; Leung PC; Jeung EB; Choi KC
    Cancer Sci; 2010 Apr; 101(4):955-62. PubMed ID: 20704576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor therapeutic effects of cytosine deaminase and interferon-β against endometrial cancer cells using genetically engineered stem cells in vitro.
    Yi BR; Kang NH; Hwang KA; Kim SU; Jeung EB; Choi KC
    Anticancer Res; 2011 Sep; 31(9):2853-61. PubMed ID: 21868529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional effects of engineered stem cells expressing a therapeutic gene and interferon-β in a xenograft mouse model of endometrial cancer.
    Yi BR; Kim SU; Choi KC
    Int J Oncol; 2015 Jul; 47(1):171-8. PubMed ID: 25963746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.
    Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC
    Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithyroid cancer effects of human neural stem cells expressing therapeutic genes on anaplastic thyroid cancer cells.
    Shin HJ; Hwang KA; Go RE; Kim SU; Choi KC
    J Cell Biochem; 2020 Feb; 121(2):1586-1598. PubMed ID: 31512776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
    Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
    Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth of K562 human leukemia cells was inhibited by therapeutic neural stem cells in cellular and xenograft mouse models.
    Park GT; Heo JR; Kim SU; Choi KC
    Cytotherapy; 2018 Sep; 20(9):1191-1201. PubMed ID: 30078654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of therapeutic genes, cytosine deaminase and interferon‑β, delivered by genetically engineered stem cells against renal cell carcinoma.
    Kim GS; Kim SM; Kim SU; Lee G; Choi KC
    Oncol Rep; 2020 Jun; 43(6):2045-2052. PubMed ID: 32236604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review).
    Yi BR; Choi KJ; Kim SU; Choi KC
    Int J Oncol; 2012 Sep; 41(3):798-804. PubMed ID: 22736197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.
    Torimura T; Ueno T; Taniguchi E; Masuda H; Iwamoto H; Nakamura T; Inoue K; Hashimoto O; Abe M; Koga H; Barresi V; Nakashima E; Yano H; Sata M
    Cancer Sci; 2012 Mar; 103(3):542-8. PubMed ID: 22151662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence.
    Taheri M; Tehrani HA; Farzad SA; Korourian A; Arefian E; Ramezani M
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113048. PubMed ID: 39236459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.